VIGL

Vigil Neuroscience, Inc.

3.41 USD
+0.02 (+0.59%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vigil Neuroscience, Inc. stock is up 27.24% since 30 days ago. The next earnings date is Mar 19, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 March’s closed higher than February.

About Vigil Neuroscience, Inc.

Vigil Neuroscience, Inc. engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) The company also develops a small molecule TREM2 agonist suitable for oral delivery.